Please use this identifier to cite or link to this item:
Title: Exhaled Breath Condensate Pepsin: Potential Noninvasive Test for Gastroesophageal Reflux in COPD and Bronchiectasis.
Austin Authors: Lee, Annemarie L;Button, Brenda M;Denehy, Linda;Roberts, Stuart;Bamford, Tiffany;Mu, Fi-Tjen;Mifsud, Nicole;Stirling, Robert;Wilson, John W
Affiliation: Physiotherapy, Melbourne School of Health Sciences, The University of Melbourne, Melbourne, Victoria, Australia
Department of Immunology, Monash University, Melbourne, Victoria, Australia
Department of Medicine Janssen Pharmaceuticals, Johnson & Johnson, Melbourne, Victoria, Australia
Department of Gastroenterology, Alfred Health, Melbourne, Victoria, Australia
Physiotherapy Department Department of Allergy, Immunology and Respiratory Medicine Department of Medicine.
Department of Medicine.
Department of Allergy, Immunology and Respiratory Medicine Department of Medicine.
Institute for Breathing and Sleep, Austin Health, Heidelberg, Victoria, Australia
Department of Physiotherapy, Austin Health, Heidelberg, Victoria, Australia
Issue Date: 28-Oct-2014
Publication information: Respiratory Care 2014; 60(2): 244-50
Abstract: Acid gastroesophageal reflux is a common problem in non-cystic fibrosis bronchiectasis and COPD. Invasive methods are used to diagnose gastroesophageal reflux, but the ability to detect pulmonary microaspiration of gastric contents using this method is unclear. A noninvasive option to detect pulmonary microaspiration is to measure pepsin in exhaled breath condensate (EBC), but this has not been related to esophageal pH monitoring in these lung conditions. This study aimed to measure pepsin concentrations and pH in EBC and to determine the relationship to gastroesophageal reflux in bronchiectasis or COPD.Subjects with bronchiectasis (n = 10) or COPD (n = 10) and control subjects (n = 10) completed 24-h esophageal pH monitoring for detection of acid gastroesophageal reflux, measuring the percentage of reflux time in the proximal esophagus and the DeMeester score (DMS). Concurrently, 3 samples of EBC were collected from each subject, and pH was measured and pepsin concentrations were analyzed by enzyme-linked immunosorbent assay.EBC pepsin was detected in subjects with bronchiectasis (44%) or COPD (56%) and in control subjects (10%). A diagnosis of gastroesophageal reflux was not associated with a higher concentration of EBC pepsin in bronchiectasis (P = .21) or COPD (P = .11). EBC pepsin concentration did not correlate with DMS (rs = 0.36) or proximal reflux index (rs = 0.25) in subjects with bronchiectasis or with DMS (rs = 0.28) or proximal reflux index (rs = 0.21) in patients with COPD. EBC and sputum pepsin concentrations were moderately correlated in bronchiectasis (rs = 0.56) and in COPD (rs = 0.43).Pepsin is detectable in EBC samples in bronchiectasis and COPD. Although no association was found between pepsin concentrations and a diagnosis of gastroesophageal reflux, a moderate relationship between sputum and EBC pepsin concentrations suggests that EBC pepsin may be a useful noninvasive marker of pulmonary microaspiration.
Gov't Doc #: 25352687
DOI: 10.4187/respcare.03570
Type: Journal Article
Subjects: COPD
exhaled breath condensate
gastroesophageal reflux
Appears in Collections:Journal articles

Show full item record

Page view(s)

checked on Nov 29, 2022

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.